Paradigm shift – Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery
- 1 July 2018
- journal article
- review article
- Published by Elsevier in Biotechnology Advances
- Vol. 36 (4) , 935-953
Abstract
No abstract availableKeywords
Funding Information
- University of Alabama
This publication has 240 references indexed in Scilit:
- The damaging effects of short chain fatty acids on Escherichia coli membranesApplied Microbiology and Biotechnology, 2013
- Targeting Neutrophil Apoptosis for Enhancing the Resolution of InflammationCells, 2013
- Experimental Evidence of-3 Polyunsaturated Fatty Acid Modulation of Inflammatory Cytokines and Bioactive Lipid Mediators: Their Potential Role in Inflammatory, Neurodegenerative, and Neoplastic DiseasesBioMed Research International, 2013
- Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in miceExperimental Gerontology, 2011
- High fat diet-induced animal model of age-associated obesity and osteoporosisThe Journal of Nutritional Biochemistry, 2010
- Specialized pro-resolving lipid mediators in the inflammatory response: An updateBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitisInflammatory Bowel Diseases, 2010
- Dietary n−6 and n−3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular preventionBiochemical Pharmacology, 2009
- Control of Oxygenation in Lipoxygenase and Cyclooxygenase CatalysisChemistry & Biology, 2007
- The seven countries study: 2,289 deaths in 15 yearsPreventive Medicine, 1984